|
Pembrolizumab (200mg IV for 30 minutes Clinical Trials
1 actively recruiting trial across 1 location
Los Angeles, California1 trial
Converting HR+ Breast Cancer Into an Individualized Vaccine
Cedars-Sinai Medical Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.